Royalty Pharma plc (RPRX) stock
RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3050% above fair value
$68.67−0.01 (-0.01%)
Close on Nov 18, 2026Market cap $39.49BP/E 39.0Yield –
Royalty Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Royalty Pharma's market cap was $39.05B on Nov 11, 2026, against $22.91B a year earlier. Over the last 5 years it ranged from $15.20B to $39.05B, with a median of $19.99B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $39.05B | +76.6% |
| 2025 | Dec 31, 2025 | $22.12B | +45.4% |
| 2024 | Dec 31, 2024 | $15.21B | -4.0% |
| 2023 | Dec 29, 2023 | $15.85B | -28.8% |
| 2022 | Dec 30, 2022 | $22.26B | +0.6% |
| 2021 | Dec 31, 2021 | $22.12B | – |
See a number that looks wrong?